Philadelphia, PA, United States of America

Vinod Krishna

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.7

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Vinod Krishna: Innovator in Biotech and Immunotherapy**

Introduction

Vinod Krishna is a distinguished inventor based in Philadelphia, PA, renowned for his contributions to the field of biotechnology and immunotherapy. With four patents to his name, his work focuses on developing innovative therapies that harness the body's immune system to combat various diseases, particularly cancer.

Latest Patents

Krishna's latest patents highlight his groundbreaking research in neoantigen peptide mimics and vaccines targeting mutant CALR and JAK2. The first patent involves polypeptide fragments and polynucleotides based on various oncogenes, including mutant capicua transcriptional repressor (CIC) and v-erb-b2 erythroblastic leukemia viral oncogene homolog B (ERBB2). This patent discloses methods for generating CD8+ T-cells and treatment methodologies that can significantly enhance immune responses against tumors. The second patent focuses on vaccines that utilize polypeptides and polynucleotides based on mutant CALR and JAK2 sequences, providing innovative methods for inducing immune responses and offering potential treatments for conditions related to specific mutations.

Career Highlights

Vinod Krishna is currently employed at Janssen Biotech, Inc., a leading biopharmaceutical company known for its innovative research in developing therapies for complex diseases. His role has allowed him to lead and contribute to significant advancements in therapeutic techniques and vaccine development in the field of immunology.

Collaborations

Throughout his career, Krishna has collaborated with esteemed colleagues, including Manuel Sepulveda and Vipul Bhargava. These partnerships have enriched his research endeavors and facilitated the sharing of knowledge and expertise, ultimately leading to advancements in the development of immunotherapies.

Conclusion

Vinod Krishna's innovative work and patented inventions reflect his commitment to advancing science and improving patient outcomes. His contributions in biotechnology, particularly in cancer immunotherapy, position him as a notable inventor and leader in the field. As he continues to collaborate and innovate, the impact of his research will likely resonate within the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…